  South Africa has more people infected with HIV but, by providing access to
anti-retroviral therapy (ART), has kept more people alive than any other
country. The effectiveness, availability and affordability of potent
anti-retroviral therapy (ART) make it possible to contemplate ending the
epidemic of HIV/AIDS. We consider what would have happened without ART, the
impact of the current roll-out of ART, what might be possible if early
treatment becomes available to all, and what could have happened if ART had
been provided much earlier in the epidemic. In 2013 the provision of ART has
reduced the prevalence of HIV from an estimated 15% to 9% among adults not on
ART, the annual incidence from 2% to 0.9%, and the AIDS related deaths from
0.9% to 0.3% p.a. saving 1.5 million lives and USD727M. Regular testing and
universal access to ART could reduce the prevalence among adults not on ART in
2023 to 0.06%, annual incidence to 0.05%, and eliminate AIDS deaths. Cumulative
costs between 2013 ands 2023 would increase by USD692M only 4% of the total
cost of USD17Bn. If a universal testing and early treatment had started in 1998
the prevalence of HIV among adults not on ART in 2013 would have fallen to
0.03%, annual incidence to 0.03%, and saved 2.5 million lives. The cost up to
2013 would have increased by USD18Bn but this would have been cost effective at
US$7,200 per life saved. Future surveys of HIV among women attending ante-natal
clinics should include testing women for the presence of anti-retroviral drugs,
measuring their viral loads, and using appropriate assays for estimating HIV
incidence. These data would make it possible to develop better and more
reliable estimates of the current state of the epidemic, the success of the
current ART programme, levels of viral load suppression for those on ART and
the incidence of infection.
